The novel coronavirus, SARS-CoV-2, which has resulted in COVID-19 disease is a highly contagious severe respiratory infection that has resulted in a global pandemic. Health care providers worldwide are trying to determine the best way to monitor, manage, and treat COVID-19 patients. Once fluid builds up in the alveoli in the lungs it prevents the lungs from filling with enough air, which in turn means less oxygen reaches the bloodstream. By not having enough oxygen the organs become deprived and begin to lose function which results in secondary complications.

The most common secondary complications are pneumonia, severe pneumonia, acute respiratory distress syndrome (ARDS), sepsis, and septic shock. The main treatment focus is obtaining ideal oxygenation (delivery and consumption), fluid balance, and cardiac function in order to reduce further complications and to ensure that the patient is maintaining appropriate levels for recovery . 

​

Supportive care such as hemodynamic monitoring has proven to be an integral part in the treatment of COVID-19 patients. The current gold standard for hemodynamic management is by using a pulmonary artery catheter (PAC) or central venous catheter (CVC). Due to the complexity and highly invasive nature of these catheters, the chance of infection and catheter-related complications is high and it has been suggested that PAC should not be used routinely in ARDS or hemodynamically unstable patients . Transthoracic Echocardiography (TTE) is an accurate and precise method for estimating cardiac hemodyanmics however it does not provide continuous measurements without a health care worker in contact with the patient and in order to achieve accurate results intensivists need to be highly trained in critical care echocardiography . Easy to use, noninvasive, and continuous hemodynamic monitoring coupled with treatment protocols is a crticial tool needed for health care workers to support and treat COVID-19 patients.